Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?

Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma

“…The median OS of these eight patients was 10.00 months, which was lower than the OS of all patients in our study, but poor nutritional status did not influence the OS significantly (P=0.324). Metastatic locations of PSC are similar to those of the other types of non-small cell lung cancer, including lung, pleura, bone, brain, and adrenal glands (14)(15)(16)(17). The metastatic locations of patients with stage-IV in our study were similar to the above.…”